Insmed (INSM) Net Margin (2010 - 2026)

Insmed (INSM) posted quarterly Net Margin of 53.46% for Q1 2026, up 22296.0% year-over-year from N/an in Q1 2025, and up 57.06% quarter-over-quarter from 124.5% in Q4 2025.

Insmed (INSM) Net Margin (2010 - 2026) Analysis & Trends

Insmed's Net Margin history runs 12 years deep, the most recent figure standing at 53.46% for Q1 2026.

  • In Q1 2026, Net Margin rose 22296.0% year-over-year to 53.46%; the TTM figure through Mar 2026 stood at 144.44% (up 12149.0% YoY), while the FY2025 annual figure was 210.54%, up 4070.0% from the prior year.
  • Net Margin for Q1 2026 stood at 53.46%, up from 124.5% in the prior quarter.
  • The five-year high for Net Margin was 53.46% in Q1 2026, with the low at 332.75% in Q2 2024.
  • The 5-year median for Net Margin is 225.53% (2024), against an average of 222.94%.
  • The sharpest annual moves came in 2023 and 2026: Net Margin tumbled 17034 bps in 2023, then jumped 22296 bps in 2026.
  • Insmed's Net Margin stood at 270.02% in 2022, then rose by 18 bps to 222.31% in 2023, then dropped by 1 bps to 225.53% in 2024, then soared by 45 bps to 124.5% in 2025, then soared by 57 bps to 53.46% in 2026.
  • Business Quant data shows INSM's Net Margin at 53.46% in Q1 2026, 124.5% in Q4 2025, and 259.95% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 30.23%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 30.33%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 13.90%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 30.98%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 12.74%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -3.12%
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn -20,152.98%

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.12%
Mar 31, 2026 -53.46%
Dec 31, 2025 -124.50%
Sep 30, 2025 -259.95%
Jun 30, 2025 -299.48%
Mar 31, 2025 -276.42%
Dec 31, 2024 -225.53%
Sep 30, 2024 -236.04%
Jun 30, 2024 -332.75%
Mar 31, 2024 -208.07%
Dec 31, 2023 -222.31%
Sep 30, 2023 -201.00%
Jun 30, 2023 -316.99%
Mar 31, 2023 -244.98%
Dec 31, 2022 -270.02%
Sep 30, 2022 -193.63%
Jun 30, 2022 -146.65%
Mar 31, 2022 -178.17%
Dec 31, 2021 -201.30%
Sep 30, 2021 -241.06%